Global /United States /Healthcare /Medical Care Facilities /OPCH
chevron_leftBack
Option Care Health, Inc. logo

Option Care Health, Inc.

OPCH
NASDAQ: OPCH Delayed
26.87USD -3.2%
As of 10 June 2026, Option Care Health, Inc. has a market cap of $4.22B USD, ranking #4276 globally and #1219 in the United States. It ranks #321 in the Healthcare sector, and #33 in the Medical Care Facilities industry.
Global Rank
4276
Country Rank
1219
Sector Rank
321
Industry Rank
33
Key Stats
Market Cap
$4.22BUSD
Enterprise Value
$5.21BUSD
Revenue (TTM)
$5.65BUSD
EBITDA (TTM)
$408.6MUSD
Net Income (TTM)
$207.59MUSD
EBITDA Margin
7.2%
Profit Margin
3.7%
PE Ratio
21.2
Forward PE
17.9
PS Ratio
0.7
PB Ratio
3.3
EV/EBITDA
12.7
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Care Facilities
CEO
John Rademacher open_in_new
Employees
8,266
Website
optioncarehealth.com open_in_new
1d 1w 1m 3m 6m 1y
-3.2% -4.3% -1.6% -23% -4.8% -19%

News

Loading...

OPCH Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NASDAQ
MIC: XNAS
PRIMARY
OPCH
Option Care Health Inc
ISIN: US68404L2016
Shares Out.:
157.028M1 Shares Float: 154.434M2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
26.87 USD
Borsa Italiana
MIC: XMIL
1OPCH
Option Care Health Inc
ISIN: US68404L2016
TV:
SA:
YF:
GF:
BA:
MS:
17.98 EUR
Mexican Bolsa
MIC: XMEX
OPCH
Option Care Health Inc
ISIN: US68404L2016
TV:
SA:
YF:
GF:
BA:
MS:
373.11 MXN
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Option Care Health, Inc.

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer’s disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. The company is headquartered in Bannockburn, Illinois.

Similar Companies

Industry: Medical Care Facilities (United States)
Name
Market Cap diff.
PE
$96.73B
2K%
14.9
$21.13B
401%
24.6
$15.78B
274%
11.6
SOLV
$11.53B
173%
7.5
ENSG
$10.89B
158%
31.9
$10.25B
143%
6.8
Industry: Medical Care Facilities (Global)
Name
Market Cap diff.
PE
$232.18B
852.82B AED
5K%
44.1
$26.49B
22.97B EUR
528%
15.0
$25.39B
22.02B EUR
502%
24.9
$22.49B
84.42B SAR
433%
35.2
$19.17B
77.85B MYR
354%
37.0
$16.35B
84.79B BRL
288%
18.1
chevron_leftBack